A000230 Stock Overview
Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Ildong Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩7,360.00 |
52 Week High | ₩12,220.00 |
52 Week Low | ₩5,470.00 |
Beta | 0.76 |
1 Month Change | 3.66% |
3 Month Change | -11.33% |
1 Year Change | -27.06% |
3 Year Change | -47.62% |
5 Year Change | -30.38% |
Change since IPO | 289.29% |
Recent News & Updates
Revenues Working Against Ildong Holdings Co., Ltd.'s (KRX:000230) Share Price
Dec 18Is Ildong Holdings (KRX:000230) Using Debt Sensibly?
Nov 12Recent updates
Revenues Working Against Ildong Holdings Co., Ltd.'s (KRX:000230) Share Price
Dec 18Is Ildong Holdings (KRX:000230) Using Debt Sensibly?
Nov 12Ildong Holdings Co., Ltd. (KRX:000230) Shares Fly 39% But Investors Aren't Buying For Growth
Aug 20Is Ildong Holdings Co., Ltd. (KRX:000230) A Good Dividend Stock?
Apr 28Can You Imagine How Ildong Holdings' (KRX:000230) Shareholders Feel About The 60% Share Price Increase?
Mar 04Ildong Holdings (KRX:000230) Has Debt But No Earnings; Should You Worry?
Feb 06Tread With Caution Around Ildong Holdings Co., Ltd.'s (KRX:000230) 0.7% Dividend Yield
Jan 11How Much Of Ildong Holdings Co., Ltd. (KRX:000230) Do Insiders Own?
Dec 16How Much Have Ildong Holdings (KRX:000230) Shareholders Earned On Their Investment Over The Last Five Years?
Nov 20Shareholder Returns
A000230 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 8.6% | 1.0% | -0.9% |
1Y | -27.1% | 2.4% | -9.0% |
Return vs Industry: A000230 underperformed the KR Pharmaceuticals industry which returned 4.3% over the past year.
Return vs Market: A000230 underperformed the KR Market which returned -9% over the past year.
Price Volatility
A000230 volatility | |
---|---|
A000230 Average Weekly Movement | 7.5% |
Pharmaceuticals Industry Average Movement | 5.6% |
Market Average Movement | 6.6% |
10% most volatile stocks in KR Market | 12.7% |
10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A000230 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A000230's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1941 | 80 | Dae-Chang Park | www.ildongholdings.co.kr |
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics.
Ildong Holdings Co., Ltd. Fundamentals Summary
A000230 fundamental statistics | |
---|---|
Market cap | ₩83.11b |
Earnings (TTM) | -₩23.92b |
Revenue (TTM) | ₩649.81b |
0.1x
P/S Ratio-3.5x
P/E RatioIs A000230 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A000230 income statement (TTM) | |
---|---|
Revenue | ₩649.81b |
Cost of Revenue | ₩424.61b |
Gross Profit | ₩225.20b |
Other Expenses | ₩249.12b |
Earnings | -₩23.92b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -2.12k |
Gross Margin | 34.66% |
Net Profit Margin | -3.68% |
Debt/Equity Ratio | 162.8% |
How did A000230 perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield-5%
Payout RatioDoes A000230 pay a reliable dividends?
See A000230 dividend history and benchmarksIldong Holdings dividend dates | |
---|---|
Ex Dividend Date | Dec 27 2024 |
Dividend Pay Date | Apr 21 2025 |
Days until Ex dividend | 2 days |
Days until Dividend pay date | 117 days |
Does A000230 pay a reliable dividends?
See A000230 dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 10:18 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ildong Holdings Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kidal Bae | Shinhan Investment Corp. |